IRIS Toxicological Review of Perfluorobutanoic Acid (PFBA) and Related Salts (Interagency Science Discussion Draft Comments, 2022)
Notice - This site contains archived material(s)
Archive disclaimer
Archive
disclaimer
Archived files are provided for reference
purposes only. These files are no longer maintained by the Agency and may be outdated. For
current EPA information, go to www.epa.gov. It is EPA's policy to
support reasonable accommodation to persons with disabilities, pursuant to the Rehabilitation
Act of 1973, 29 U.S.C. 791. If you need assistance with accessing archived files, contact
EPA's Reasonable Accommodations
or submit a request using the Contact Us form.
Abstract
In December 2022, EPA finalized the IRIS Assessment of Perfluorobutanoic Acid (PFBA) and Related Salts. The Toxicological Review was reviewed internally by EPA and by other federal agencies and White House Offices after public release in Aug 2021. Consistent with the May 2009 IRIS assessment development process, all written comments on IRIS assessments submitted by other federal agencies and White House Offices are made publicly available on this site.
Impact/Purpose
EPA is undertaking development of the Integrated Risk Information System (IRIS) health assessment for PFBA. The comments from the Interagency Science Discussion Draft were used to update IRIS Toxicological Review and Executive Summary for PFBA that will be entered into the IRIS database.
Status
Now that the interagency review draft has been completed and finalized, the PFBA assessment has been loaded into the IRIS Web site and Database.
- 1. DoD PFBA IASD Comments Oct2022 (PDF) (15 pp, 174 KB, about PDF)
- 2. NIEHS PFBA IASD Comments Oct2022 (PDF) (3 pp, 226 KB, about PDF)
- 3. NIOSH PFBA IASD Comments Oct2022 (PDF) (1 pp, 90 KB, about PDF)
- 4. OMB PFBA IASD Comments Oct2022 (PDF) (2 pp, 118 KB, about PDF)